Melanoma-associated antigen D4 (MAGE-D4 antigen) (MAGE-E1 antigen)
1_MAEGS 6_ FSVQS 11_ ESYSV 16_ EDMDE 21_ GSDEV 26_ GEEEM 31_ VEGND 36_ YEEFG 41_ AFGGY 46_ GTLTS 51_ FDIHI 56_ LRAFG 61_ SLGPG 66_ LRILS 71_ NEPWE 76_ LENPV 81_ LAQTL 86_ VEALQ 91_ LDPET 96_ LANET 101_ AARAA 106_ NVARA 111_ AASNR 116_ AARAA 121_ AAAAR 126_ TAFSQ 131_ VVASH 136_ RVATP 141_ QVSGE 146_ DTQPT 151_ TYAAE 156_ AQGPT 161_ PEPPL 166_ ASPQT 171_ SQMLV 176_ TSKMA 181_ APEAP 186_ ATSAQ 191_ SQTGS 196_ PAQEA 201_ ATEGP 206_ SSACA 211_ FSQAP 216_ CAREV 221_ DANRP 226_ STAFL 231_ GQNDV 236_ FDFTQ 241_ PAGVS 246_ GMAFP 251_ RPKRP 256_ APAQE 261_ AATEG 266_ PSAAS 271_ GVPQT 276_ GPGRE 281_ VAATR 286_ PKTTK 291_ SGKAL 296_ AKTRW 301_ VEPQN 306_ VVAAA 311_ AAKAK 316_ MATSI 321_ PEPEG 326_ AAAAT 331_ AQHSA 336_ EPWAR 341_ MGGKR 346_ TKKSK 351_ HLDDE 356_ YESSE 361_ EERET 366_ PAVPP 371_ TWRAS 376_ QPSLT 381_ VRAQL 386_ APRPP 391_ MAPRS 396_ QIPSR 401_ HVLCL 406_ PPRNV 411_ TLLQE 416_ RANKL 421_ VKYLM 426_ IKDYK 431_ KIPIK 436_ RADML 441_ KDVIR 446_ EYDEH 451_ FPEII 456_ ERATY 461_ TLEKK 466_ FGIHL 471_ KEIDK 476_ EEHLY 481_ ILVCT 486_ RDSSA 491_ RLLGK 496_ TKDTP 501_ RLSLL 506_ LVILG 511_ VIFMN 516_ GNRAS 521_ EAVLW 526_ EALRK 531_ MGLRP 536_ GVRHP 541_ FLGDL 546_ RKLIT 551_ DDFVK 556_ QKYLE 561_ YKKIP 566_ NSNPP 571_ EYEFL 576_ WGLRA 581_ RHETS 586_ KMRVL 591_ RFIAQ 596_ NQNRD 601_ PREWK 606_ AHFLE 611_ AVDDA 616_ FKTMD 621_ VDMAE 626_ EHARA 631_ QMRAQ 636_ MNIGD 641_ EALIG 646_ RWSWD 651_ DIQVE 656_ LLTWD 661_ EDGDF 666_ GDAWA 671_ RIPFA 676_ FWARY 681_ HQYIL 686_ NSNRA 691_ NRRAT 696_ WRAGV 701_ SSGTN 706_ GGAST 711_ SVLDG 716_ PSTSS 721_ TIRTR 726_ NAARA 731_ GASFF 736_SWIQH
1: May enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex